Trials / Completed
CompletedNCT03153020
Determinants of Adherence to Post-stroke/Transient Ischemic Attack Secondary Prevention Treatment: Cohort Study in the Rhône
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 633 (actual)
- Sponsor
- Hospices Civils de Lyon · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The effectiveness of emergency management of acute ischemic stroke has improved considerably in recent years with thrombolysis and more recently thrombectomy. This improvement is accompanied by an increase in the number of stroke survivors. One of the major issues for these ever-increasing survivors is the prevention of recurrence. According to data from the 3 French registries, more than 20% of patients have at least one recurrence. Secondary prevention treatment has demonstrated his efficacy to prevent stroke recurrence. This evolution justifies identifying factors associated with adherence to secondary prevention treatment, measured at 1 year post-stroke / transient ischemic attack (TIA), in patients included in the STROKE 69 cohort.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Patients with stroke or transient ischemic attack | Determination of factors associated to the conformity to secondary prevention treatment 1, 2 and 3 years post a stroke or transient ischemic attack. |
Timeline
- Start date
- 2017-09-11
- Primary completion
- 2018-12-31
- Completion
- 2019-12-31
- First posted
- 2017-05-15
- Last updated
- 2025-11-25
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT03153020. Inclusion in this directory is not an endorsement.